Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Secures $23M for AI-Enabled Digital Pathology Solutions

Proscia
By Author Proscia | December 1, 2020

Proscia, a Philadelphia-based provider of digital and computational pathology solutions, today announced it has secured $23M in Series B funding  led by Scale Venture Partners, with participation from Hitachi Ventures, the strategic corporate venture capital arm of Hitachi, Ltd., bringing its funding total to $35 million.

Our website uses cookies. By using this site, you agree to its use of cookies.